Acoltremon

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameAcoltremon
Drug Alias NameFema Gras 4681TRYPTYRAR-15512AVX-012WS-12 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 agonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsDry Eye SyndromesXerophthalmia
Global Approved IndicationsDry Eye Syndromes
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/05/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesInstituto De Neurociencias De Alicante
China Registration ClassN/A

Develop Information

Active CompaniesAerie Pharmaceuticals IncOcumension Therapeutics (Suzhou) Co LtdAlcon Laboratories Inc
Inactive CompaniesAlcon
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank